The Latest in Conference Coverage

Venetoclax plus ibrutinib yields encouraging MRD results in first-line CLL

June 8, 2018

Indolent Lymphoma

Chemo-free regimen appears viable in previously untreated FL

June 7, 2018

Aggressive Lymphomas

Novel antibody shifts ‘eat me/don’t eat me’ balance in refractory NHL

June 6, 2018

Aggressive Lymphomas

Ibrutinib plus rituximab amped PFS in Waldenström’s

June 1, 2018

Indolent Lymphoma

Pediatric cancers are on the rise

May 17, 2018

Aggressive Lymphomas

Early results favor combo IL-15/anti-CD20 in indolent NHL

May 3, 2018

Indolent Lymphoma

VIDEO: How to prepare PTCL patients for transplant

March 27, 2018

Aggressive Lymphomas

CAR T before transplant yields durable remission in B-cell malignancies

March 14, 2018

Aggressive Lymphomas

Outpatient CAR T infusions feasible using liso-cel

March 12, 2018

Aggressive Lymphomas

Best options for treating relapsed/refractory PTCL

March 8, 2018

Aggressive Lymphomas

Mycosis fungoides increases risk for second cancers

February 28, 2018

Indolent Lymphoma

Basiliximab/BEAM may improve post-ASCT outcomes in PTCL

February 21, 2018

Aggressive Lymphomas

A view from the bridge to transplant for PTCL

February 14, 2018

Aggressive Lymphomas

Getting hematologic cancer drugs on the fast track

February 9, 2018

Aggressive Lymphomas

T-cell lymphoma therapies on the horizon

February 9, 2018

Aggressive Lymphomas